Same Job, Different Paycheck: What Sales Careers Actually Pay in 2025-26
The range across U.S. sales roles runs from $34K to $705K. Same country, same year, same job title on a business card. Industry choice is the biggest salary decision most reps ever make.
The range across U.S. sales roles runs from $34K to $705K.
That is not a typo. It is the same country, the same year, and often the same job title on a business card. A sales rep in retail and a sales rep in enterprise software both carry a quota and both close deals. The economics underneath those two jobs have almost nothing in common.
We ranked what salespeople actually take home across eight industries, then went one layer deeper into medical technology, where the spread inside a single industry is as wide as the spread across all of them combined.
The Full Picture
Eight industries, ranked by top-earner ceiling.
| Industry | Average | Top 5% |
|---|---|---|
| Enterprise SaaS | $265K | $705K |
| Sales Engineer (Tech) | $200K | $390K |
| Medical Devices | $157K | $348K |
| Financial Services | $146K | $300K |
| Pharma Sales | $141K | $205K |
| Industrial / Manufacturing | $120K | $210K |
| Real Estate | $63K | $200K |
| Retail Sales | $34K | $60K |
Enterprise SaaS sits at the top for a reason that has nothing to do with the reps being better sellers. Inside technology alone, the range is just as wide: an Enterprise SaaS account executive selling into Fortune 500 buyers on 12 to 18 month cycles averages $265K and tops out at $705K, while a sales engineer closing the same category of deal on technical merit averages $200K and tops out at $390K. A mid-market AE working $50K to $250K contracts on faster cycles averages $175K with a $391K ceiling. An SMB AE running high-velocity, high-activity plays averages $130K with a $269K ceiling.
Four seats in the same building. Four different economic games.
Medical Devices Is Not One Job
The eight-industry table above shows Medical Devices at $157K average, $348K ceiling. That number is an average of ten different jobs that get filed under one label.
| Specialty | Average OTE | Top Performers (90th percentile) |
|---|---|---|
| Spine Devices | $300K | $600K+ |
| Surgical Robotics | $200K | $520K+ |
| Orthopedic Trauma | $220K | $400K+ |
| Joint Reconstruction | $200K | $400K+ |
| Capital Equipment | $175K | $400K+ |
| Biotech / Biologics | $199K | $350K+ |
| Cardiovascular | $175K | $350K+ |
| Sports Medicine | $180K | $300K+ |
| Pharma Sales | $141K | $273K+ |
| Diagnostic Imaging | $125K | $220K+ |
A rep selling spine devices averages $300K, nearly double the industry-wide medical device average, before the top-performer number even enters the conversation. A rep in diagnostic imaging, working the same hospitals, often the same buying committees, averages $125K. Both carry a bag into the same building. Neither one would describe the other's job as similar to their own.
Why the Gap Exists
Three levers explain the entire chart, in medtech and everywhere else.
Average contract value. Enterprise SaaS closes seven-figure deals. A spine device case runs $15K to $40K in implants. Retail rings up an $80 shirt. The size of what gets sold sets the ceiling on what selling it can pay, before anything else is considered.
Quota hit rate. Only about 40% of enterprise AEs hit quota in a given year. The top 5% are not simply better at the same job. They ride uncapped commissions and accelerators that only activate once a rep clears the number, which is exactly why the ceiling separates so sharply from the average in every high-ACV category.
Pay mix. The base-to-variable split changes what the job actually is. SaaS runs close to 50/50 against recurring revenue. Medtech typically runs 60/40 with a capital equipment bonus layered on top. Retail runs 90/10 and caps out fast. A rep on a heavier variable mix is playing a different game than a rep on a heavier base, even inside the same company.
What This Means for Commercial Leaders
If you are building or benchmarking a commercial team, the industry label on the org chart tells you less than the specialty does. A team built entirely of "medical device reps" could be running four different economic models depending on whether the bag holds spine implants, capital equipment, or diagnostic imaging contracts, and a compensation plan built for one of those models will systematically under-reward or over-pay the others.
The same logic applies to hiring. A rep who thrived on high-ACV, long-cycle spine sales is not automatically suited to a high-velocity diagnostic imaging territory, and the compensation structure that motivated one will demotivate the other. Deal size, quota design, and pay mix are commercial architecture decisions, not market conditions you inherit. Get the architecture wrong and the org chart will look identical to a competitor's while the pipeline velocity underneath it moves at a completely different speed.
Which specialty surprised you? If you are deciding where to build or where to compete, that is the conversation worth having before the next comp plan gets drafted.
Dr. Gunter Wessels is the founder of LiquidSMARTS℠, a commercial engineering firm for medical technology companies. LiquidSMARTS℠ guarantees a 10% pipeline velocity improvement in 90 days.
Sources: BLS, RepVue, Bridge Group, MedReps, SLR Medical, Everstage, Glassdoor, CaptivateIQ (2025-26).